期刊文献+

145例乳腺癌骨转移临床病理分析 被引量:6

Clinical analysis on 145 cases of bone metastases in breast cancer
原文传递
导出
摘要 目的:探讨乳腺癌骨转移的相关因素及处理对策。方法:本文对1954年1月~1977年12月我院收治的2803例原发乳腺癌术后发生骨转移的145例患者临床资料进行回顾性分析。结果:乳腺癌术后骨转移发生率5.1%,骨转移部位分布较广泛,多数出现在脊柱,术后前5年发生率占76.4%,腋淋巴结阳性患者较阴性患者较早发生转移。出现转移后经治疗患者较未治疗患者生存期有显著性差异。结论:乳腺癌术后骨转移出现时间与其分布有其规律,综合治疗后乳腺癌患者可延缓出现转移的时间。出现骨转移后,积极治疗,可达到延长生存期改善生存质量的目的。 Objective: To evaluated the related factor and treatment of bone matastases of breast cancer. Methods:From January 1954 to December 1977,145 cases of bone metastasis of breast cancer were retrospective studied. Results: The rate of bone matastasis was 5.1%(145/2803),vertebrae tend to be the commonest sites for metastasis.76.4% patients with bone metastasis occurrence in first five years.Bone metastasis was related to various poor prognostic factor:Spread to lymph nodes and stage. The survival time of the patients with the treatment was significantly higher than that without treatment. Conclusions: Systemic treatment can deley the occurrence of bone metastasis and can also prolong the survival after the occurrence of bone metastasis.
出处 《齐鲁肿瘤杂志》 1999年第2期120-122,共3页
关键词 乳腺癌 骨转移瘤 临床病理 breast cancer bone metastasis treatment
  • 相关文献

参考文献2

  • 1詹友庆 朱少立 等.影响乳腺癌术后骨转移的因素[J].中国肿瘤临床,1988,15(3):171-171.
  • 2孙如荣 杨天锡 等.乳腺癌骨转移临床X线分析[J].肿瘤防治研究,1986,13(2):105-105.

同被引文献34

  • 1顾兴华,夏康适.骨转移癌药物治疗近况[J].国外医学(肿瘤学分册),1994,21(4):233-234. 被引量:8
  • 2宋三泰 汤仲明 等.乳癌组织取样、保存及测定方法对ER测定量的影响及其意义[J].中华肿瘤杂志,1985,7:351-353.
  • 3Martin TJ, Moseley JM. Mechanisms in the skeletal complications of breast cancer [ J]. Endoer Relat Cancer,2000,7:271 - 284.
  • 4Huber S,Ulsperger E,Gomar C. et al. Osseous metastases in breast cancer: radiographic monitoring of therapeutic response [ J]. Anticancer Res ,2002,22 : 1279 - 1288.
  • 5Soiomayer EF, Diel IJ. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis [ J]. Breast Cancer Res Treat,2000,59:271 -278.
  • 6Mundy GR. Metastasis to hone:causes, consequences and therapeutic opportunities[J]. Nat Rev Cancer,2002,2:584 -593.
  • 7Mundy GR, Martin TJ. Pathophysiology of skeletal complications of cancer[ A]. Mundy GR , Martin TJ, eds. Physiology and pharmacology of bone [M]. Berlin :Springer-Verlag,1993:641 -671.
  • 8Colleoni M, ONeill A , GOldhirsch A , et al. Identifying breast cancer patients at high risk for bone metastases [ J]. J Clinoncol, 2000,18( 23 ) :3925 -3935.
  • 9Mitsuru K , Masataka Y, Fujio K, et al. What do breast cancer patients benefit from staging bone scintigraphy[ J ] ? Jpn J Clinoncol, 2001,31 ( 6 ):263-269.
  • 10Barak V, Nisman B, Roisman I, et al. TPS in assessing response to therapy and prognosis of breast cancer patients treated with interferons[J]. J Tumor Marker Oncol, 1997, 12:17.

引证文献6

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部